2型糖尿病患者肢端感染的危险因素分析

下载PDF

导出

摘要我院自2000年1月～2005年4月收治的糖尿病合并肢端感染48例中有7例为手指端的感染,8例为小腿胫前的感染,其共同的临床特点和危险因素分析如下：

作者周泽华成艳赵显为况小璐

机构地区涪陵中心医院内分泌科

出处《现代医药卫生》 2007年第16期2443-2444,共2页 Journal of Modern Medicine & Health

关键词危险因素糖尿病患感染肢端 2型小腿胫前临床特点

参考文献8

1王玉珍,许樟荣,胡成玮.糖尿病足患者的临床特点及住院费用分析[J].中华老年多器官疾病杂志,2003,2(4):271-274. 被引量：34
2常宝成,潘从清,曾淑范.208例糖尿病足流行病学及临床特点分析[J].中华糖尿病杂志（1006-6187）,2005,13(2):129-130. 被引量：155
3Helaine E,Elizabeth A,Robert lindsay,et al.Relation of lower-Extremity Amputation to All-Cacuse and Cardiovascular Disease Mortality in American Indians[J].Diaetes Care,2004,27(7):1286.
4Ramsey SD,Newton K,Blough D.Incidence outcomes and cost of foot ulcers in patients with diabetes[J].Diab-etes Care,1999,22:382.
5夏苏建,杨莉,胡善联.糖尿病及其并发症患者的住院费用分析[J].中国医院管理,2004,24(9):40-42. 被引量：21
6王露.糖尿病足38例临床分析[J].中国实用内科杂志,2004,24(2):110-110. 被引量：3
7Charles L.Saltzman,MD,Rola Rashid,MD,Andrea Hayes,Chris Fellner,BA.4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients[J].The Journal of Bone and Joint Surgery.JBJS.ORG,2004,86-A(4):717.
8胡素银,郭晓华,方荣,毛红仙,楼雪勇,桑玉明.26例糖尿病足患者下肢血管造影检查结果分析[J].浙江医学,2004,26(3):201-202. 被引量：2

1许樟荣,王玉珍,王先从,伍春荣,余红亚,胡莲娜,杨晋德,黄列军,杨文生,刘先华,韦丽青,敬华,李淑媛.糖尿病慢性并发症与糖尿病治疗关系的调查[J].中华医学杂志,1997,77(2):119-122. 被引量：82
2[1]Xu ZR, Wang YZ, Hu CW, et al. Analysis on medical cost in diabetic patients with foot problems in China.Diabetes Res Clin Pract,2002,56(Suppl 1):S37-S38.
3[3]Boulton AJM. Foot problems in patients with diabetes mellitus. In: Pickup J, Williams G, eds. Textbook of Diabetes. 2nd ed. London: Blackwell, 1997.58.
4[6]Ouriel K Peripheral arterial disease.Lancet,2001,358:1257-1264.
5[8]Hu JS, Ma XY, Jing DQ, et al. Investigation of the incidence and complication of the diabetic foot in inpatients from 1991-2001. Diabetes Res Clin Pract,2002,56(Suppl 1):S104.
6[1]Gvain LA,Stess RM,goldstone J,et al.Prevention and treatment of foot problems in diabetes mellitus:a comprehensive program.West J Med,1993,158(1):47-52
7[1]WHO.The World Health Report[M].Geneva:Publication of WHO,1998.91
8[3]Raikou M, McGuire A. The economics of screening and treatment in type 2 diabetes mellitus[J]. Pharmacoceonomics, 2003, 21 (8):543 - 564
9[4]Costa B, Arroyo J, Sabate A. The economics of pharmacotherapy for diabetes mellitus [J]. Pharmacoeconomics, 1997,11 (2): 139 - 158
10[5]Hogan P, Dall T, Nikolov P. American Diabetes Association. Economic costs of diabetes in the US in 2002[J]. Diabetes Care, 2003, 26(3):917-932

现代医药卫生

2007年第16期

内容加载中请稍等...